- Home
- STX vs GSK Comparison
STX vs GSK Comparison
Compare STX & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$380.49
HOLD
Current Price
$54.18
Company Overview
Basic Information| Metric | STX | GSK |
|---|---|---|
| Founded | 1978 | 1715 |
| Country | Singapore | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.1B | 96.1B |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | STX | GSK |
|---|---|---|
| Price | $380.49 | $54.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 2 |
| Target Price | ★ $385.11 | N/A |
| AVG Volume (30 Days) | 3.0M | ★ 4.4M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | 0.78% | ★ 3.25% |
| EPS Growth | ★ 328.48 | N/A |
| EPS | ★ 5.03 | N/A |
| Revenue | ★ $7,384,000,000.00 | N/A |
| Revenue This Year | $27.67 | $6.81 |
| Revenue Next Year | $25.06 | $4.74 |
| P/E Ratio | $75.09 | ★ $32.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.21 | $32.38 |
| 52 Week High | $459.84 | $61.70 |
Technical Indicators
Market Signals| Indicator | STX | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 45.74 | 46.87 |
| Support Level | $350.10 | $47.89 |
| Resistance Level | $459.63 | $60.37 |
| Average True Range (ATR) | 24.44 | 0.98 |
| MACD | -0.16 | -0.11 |
| Stochastic Oscillator | 28.94 | 52.67 |
Price Performance
Historical Comparison STX
GSK
About STX Seagate Technology Holdings PLC (Ireland)
Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.